News brief
On 2026/9/30, according to genztech, US space pharmaceutical company Varda Space Industries raised USD251 million in Series D financing. Investors included Lux Capital and Natural Capital. The company manufactures drug crystals in orbit.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- genztech.blog ↗Published Sep 30, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月30日，据genztech报道，美国太空制药公司Varda Space Industries完成2.51亿美元D轮融资，投资方包括Lux Capital与Natural Capital。公司在轨道上开展药物结晶制造。